Eva Feldman, M.D., Ph.D.
Russell N. DeJong Professor of Neurology
Professor, Neurology
Director, ALS Center of Excellence
Director, NeuroNetwork for Emerging Therapies
November 8, 2022
The Possibility of Using Lipid Biomarkers to Predict Diabetic Neuropathy
“As we learn more about the relationship between serum lipid species and neuropathy, it will open up the possibility of targeted therapeutic treatment, both with drugs and lifestyle interventions,” Feldman and colleagues note.
